Pharmerica Corporation is an American company that provides long term care pharmacy services.

According to the Complaint, this is a shareholder class action brought on behalf of the former holders of PharMerica Corporation common stock against PharMerica, its board of directors, Kohlberg Kravis Roberts & Co. L.P. (“KKR”) and Walgreens Boots Alliance, Inc. (“WBA”), for violations of federal law arising out of allegedly false and misleading statements made in connection with the go-private sale of the Company to KKR, with WBA as minority investor, for $29.25 per share in cash representing a deal valued at approximately $1.4 billion.

On July 30, 2018, Plaintiffs voluntarily dismissed all of their claims against one of the Defendants. On December 17, the Court issued an Order appointing Lead Plaintiff and Counsel. Defendants filed Motions to Dismiss on January 31, 2019. On September 24, the Court issued an Order granting Defendants' Motions to Dismiss.